PERFAN

This brand name is authorized in Malta, Netherlands, United Kingdom

Active ingredients

The drug PERFAN contains one active pharmaceutical ingredient (API):

1 Enoximone
UNII C7Z4ITI7L7 - ENOXIMONE

Enoximone, an imidazolone, has both positive inotropic and vasolidator properties, inhibiting cardiac phosphodiesterase III with an increase in cAMP.

Read about Enoximone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PERFAN Concentrate for solution for injection or infusion Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C01CE03 Enoximone C Cardiovascular system → C01 Cardiac therapy → C01C Cardiac stimulants excl. cardiac glycosides → C01CE Phosphodiesterase inhibitors
Discover more medicines within C01CE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 40836
Country: MT Medicines Authority Identifier(s): AA565/42501
Country: NL Z-Index G-Standaard Identifier(s): 14628147
Country: NL Z-Index G-Standaard, PRK Identifier(s): 29386

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.